Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
Baige Online Shares Soar 333% in Hong Kong IPO Debut as AI Insurance Demand Lifts Chinese Listings 
Open-Source AI Models Gain Ground as Enterprises Seek Lower-Cost Alternatives, Citi Says 
Australia Plans Higher Fines for Social Media Firms Failing to Block Underage Users 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
Lenovo Shares Slide as AI-Driven Memory Demand Signals Higher DRAM and NAND Prices 
Italy Investigates Microsoft Over Microsoft 365 AI Subscription Price Hike 
OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal 
SoftBank Shares Slide as OpenAI IPO Delay Concerns Weigh on AI Investment Outlook 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
SpaceX Eyes Starlink Mobile Phone Service to Challenge Verizon, AT&T, and T-Mobile 
Republican Lawmaker Introduces AI Incident Reporting Bill to Strengthen U.S. AI Safety 
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
In what appears to be a strategic move to diversify its business, Alphabet Inc has relaunched its Life Sciences division as a new spinoff company known as Verily. In an introductory video, former Google showed that Verily will be focusing more on health sciences and how it will provide solutions or studies to combat or manage diseases, the Verge notes. Its standalone website, verily.com, is also live as well.
"As a life sciences team within Google[x], we were able to combine the best of our technology heritage with expertise from across many fields. Now, as an independent company, Verily is focused on using technology to better understand health, as well as prevent, detect, and manage disease," the website read.
Endgadget said that the new Verily is working on more wearables, among other projects, to achieve their goals. One goal is reportedly using wearables to detect cancer cells at very early stages in patients. Verily is also targeting to partner with third-party firms who have the technology to help the former achieve its goals.
